Literature DB >> 11877354

Mechanism of the blood pressure--raising effect of cocaine in humans.

Meryem Tuncel1, Zhongyun Wang, Debbie Arbique, Paul J Fadel, Ronald G Victor, Wanpen Vongpatanasin.   

Abstract

BACKGROUND: Although the sympathomimetic actions and cardiovascular complications of cocaine are ascribed to inhibition of norepinephrine (NE) reuptake, this hypothesis has not been tested in humans. We asked (a) whether cocaine can inhibit NE reuptake in the human peripheral circulation and (b) whether the NE-mediated peripheral vasoconstriction is the main mechanism mediating blood pressure-raising effect of cocaine. METHODS AND
RESULTS: In 15 healthy cocaine-naive subjects, we measured blood pressure, forearm blood flow, and forearm venous NE concentration during administration of (a) intrabrachial cocaine (0.15 and 15 mg), which produced no systemic neurohormonal effects, and (b) intranasal cocaine (2 mg/kg). Intrabrachial cocaine (0.15 mg) increased venous forearm NE concentration by 82% and vascular resistance by 71% (P<0.01). Increasing the intrabrachial cocaine dose by 100-fold to match the venous cocaine level of massive cocaine overdose caused a small additional increase in venous forearm NE concentration without causing significant additional vasoconstriction. Although intranasal cocaine (2 mg/kg) matched the venous cocaine concentrations caused by 0.15 mg of intrabrachial cocaine, venous NE concentration was unchanged as sympathetic nerve activity (SNA) decreased reflexively as the result of an increase in blood pressure. When SNA was restored to baseline by blunting the cocaine-induced rise in blood pressure (baroreflex activation) with nitroprusside, venous NE concentration increased to the same level caused by intrabrachial cocaine.
CONCLUSIONS: In healthy cocaine-naive individuals, cocaine can inhibit NE reuptake in the human peripheral circulation. However, this mechanism does not contribute importantly to the blood pressure-raising effect of cocaine because activation of baroreceptor reflexes decreases SNA, the neural stimulus for NE release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877354     DOI: 10.1161/hc0902.104714

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

2.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

3.  Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder.

Authors:  Benjamin W Van Tassell; Peter Westman; Cory Trankle; Sade Johns; Dinesh Kadariya; Leo Buckley; Salvatore Carbone; Antonio Abbate; Frederick Gerard Moeller
Journal:  J Cardiovasc Pharmacol       Date:  2019-12       Impact factor: 3.105

4.  Effects of anesthetic and sedative agents on sympathetic nerve activity.

Authors:  Xiao Liu; Perry L Rabin; Yuan Yuan; Awaneesh Kumar; Peter Vasallo; Johnson Wong; Gloria A Mitscher; Thomas H Everett; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2019-06-25       Impact factor: 6.343

Review 5.  Drug-Induced Hypertension: Focus on Mechanisms and Management.

Authors:  Alexandra R Lovell; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

6.  Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients.

Authors:  Chiang-Shan R Li; Peter T Morgan; David Matuskey; Osama Abdelghany; Xi Luo; Jeremy L K Chang; Bruce J Rounsaville; Yu-shin Ding; Robert T Malison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

7.  Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity.

Authors:  Xiaolei Shi; Dan Yao; Blake A Gosnell; Chi Chen
Journal:  J Lipid Res       Date:  2012-08-19       Impact factor: 5.922

8.  Cocaine action on peripheral, non-monoamine neural substrates as a trigger of electroencephalographic desynchronization and electromyographic activation following i.v. administration in freely moving rats.

Authors:  M S Smirnov; E A Kiyatkin
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

9.  Cocaine-induced vasoconstriction in the human coronary microcirculation: new evidence from myocardial contrast echocardiography.

Authors:  Swaminatha V Gurudevan; Michael D Nelson; Florian Rader; Xiu Tang; Joshua Lewis; Jimmy Johannes; J Todd Belcik; Robert M Elashoff; Jonathan R Lindner; Ronald G Victor
Journal:  Circulation       Date:  2013-06-28       Impact factor: 29.690

10.  Methylphenidate remediates error-preceding activation of the default mode brain regions in cocaine-addicted individuals.

Authors:  David Matuskey; Xi Luo; Sheng Zhang; Peter T Morgan; Osama Abdelghany; Robert T Malison; Chiang-shan R Li
Journal:  Psychiatry Res       Date:  2013-08-23       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.